Home » Headlines » Currently Reading:

Morning Headlines 3/14/17

March 13, 2017 Headlines 1 Comment

 ECRI Institute Names Top 10 Patient Safety Concerns for 2017

ECRI’s Top 10 Patient Safety Concerns for 2017 includes information management in EHRs and use of clinical decision support tools.

Trump chooses Gottlieb to run FDA; Pharma breathes sigh of relief

President Trump nominates industry favorite Scott Gottlieb, MD to lead the FDA.

HHS secretary expresses concern on bill allowing employers to demand genetic tests

HHS Secretary Tom Price voices concern over the a House bill that would grant employers access to employee genetic test results.

Former Vice President Joe Biden at SXSW 2017: ‘Your government’ is how curing cancer ‘gets done’

Joe Biden speaks about the Cancer Moonshot Task Force and its future with the new administration at SXSW.

View/Print Text Only View/Print Text Only


HIStalk Featured Sponsors

     

Currently there is "1 comment" on this Article:

  1. I had to look into this again because I had forgotten the details, but the NCI Cancer Moonshot project begun under Joe Biden and Barack Obama is different from the Cancer Moonshot 2020 project bankrolled by the infamous NantHealth CEO Patrick Soon-Shiong (who coincidentally announced his project ONE DAY before Biden’s 2016 announcement). Soon-Shiong was actually sued over his use of the doppelgänger and his project has since been renamed Cancer Breakthroughs 2020. This is the same guy that STAT blasted a few weeks ago for potentially embezzling millions of dollars through “charitable giving” to a research university. Some have speculated that his budding friendship with Donald Trump suggests he is reaching to take over the NCI’s Moonshot project.







Subscribe to Updates

Search


Loading

Text Ads


Report News and Rumors

No title

Anonymous online form
E-mail
Rumor line: 801.HIT.NEWS

Tweets

Archives

Founding Sponsors


 

Platinum Sponsors


 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Gold Sponsors


 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Reader Comments

  • Vaporware?: JTR, Cerner is re-tooling itself from a software company (sic) into a service company. The company needs a place to put ...
  • Dave Butler: Many similar issues that I've found as well during my time with provider groups. The EHRs screen can be really busy and ...
  • Justa Trench Rat: Nice to see Cerner continuing with their new campus. I am sure our implementation of their highly questionable revenue ...
  • FRANK POGGIO: Shows to go ya...answering black and white Jeopardy questions is a far cry from the massive grey area of medicine/pharma...
  • Number Cruncher: You are right AC. The cost is seriously underestimated here. Just looking at the numbers - $1 B for 5 years = $200 M ...
  • Abraham Van Helsing: Re Theranos. Will be interesting to follow the saga. As I and others had noted going back 2+ years, something was obvi...
  • Prof. Moriarty: Re: Watson pull out. I've not been directly involved with this product, but from its beginning I have always seen Watso...
  • mih: Of course they can, and for much much cheaper. But why would they do it? Existing arrangement works for everyone in the ...
  • Andrew M. Harrison: Thanks for (actually) reading our paper. I enjoyed the story of your friend, as well as the translation of numbers to em...
  • Mike: I would love to see this type of discussion around Blockchain. It is being hyped heavily currently. Yet, I wonder how we...

RSS Industry Events

  • An error has occurred, which probably means the feed is down. Try again later.

Sponsor Quick Links